Influenza Hemagglutinin (HA) Peptide: Benchmark Epitope Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid tag derived from the human influenza virus hemagglutinin protein. Its high purity (>98%) and robust solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) enable reliable use in immunoprecipitation and protein purification workflows (APExBIO A6004). The HA tag peptide facilitates competitive binding to Anti-HA antibodies for the elution of HA-tagged fusion proteins, ensuring high specificity and reproducibility in molecular biology experiments (Wei et al., 2021). Its adoption as a standard molecular biology reagent is supported by both peer-reviewed studies and benchmarked product analyses. Proper storage conditions and awareness of use limitations maximize its functional performance in protein-protein interaction research.

Biological Rationale

The HA tag is a widely used epitope tag in molecular biology, derived from the influenza virus hemagglutinin protein. It consists of nine amino acids (YPYDVPDYA) and is incorporated into recombinant fusion proteins to facilitate their detection and purification (GDC-0449 article). The tag is not naturally present in most expression systems, minimizing background signal during immunodetection. Its use enables researchers to track, isolate, and analyze target proteins without the need for protein-specific antibodies. The HA tag's small size reduces disruption to protein structure and function, which is critical for accurate protein-protein interaction studies. The tag is recognized with high affinity and specificity by monoclonal Anti-HA antibodies, allowing for sensitive detection in Western blotting, immunoprecipitation, and immunofluorescence assays (Angiotensin-1-2-1-9 article).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide operates as a competitive ligand for Anti-HA antibodies. When introduced into an immunoprecipitation workflow, the free HA peptide competes with HA-tagged fusion proteins for antibody binding sites (LabPE article). This competitive displacement enables the elution of bound HA-tagged proteins from antibody-coupled beads or columns. The process is highly specific due to the monoclonal antibody's strong affinity for the HA epitope sequence. Optimized concentrations of the peptide (typically 0.1–1 mg/mL in elution buffer) are used to achieve quantitative elution without denaturing the target protein. The peptide’s high solubility in water, DMSO, and ethanol allows seamless integration into a variety of buffer systems. Its chemical stability is maintained when stored desiccated at -20°C, but peptide solutions should be freshly prepared for each use to avoid degradation (APExBIO A6004).

Evidence & Benchmarks

• HA tag peptide enables the specific elution of HA-tagged fusion proteins from anti-HA antibody matrices, with reported elution efficiencies exceeding 90% under optimized conditions (Wei et al., 2021).
• Purity of >98% by HPLC and MS is required for reproducible immunoprecipitation, as demonstrated in comparative analyses of commercial HA peptides (LabPE article).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water, supporting use in diverse buffer systems (APExBIO).
• High-affinity competitive binding to Anti-HA antibodies confirmed by displacement assays and Western blot analysis (GDC-0449 article).
• Functional compatibility with magnetic bead-based and agarose-based immunoprecipitation workflows (AP24534 article).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely used as a protein purification tag, epitope tag for protein detection, and tool for protein-protein interaction studies. Its applications include:

• Competitive elution of HA-tagged proteins during immunoprecipitation with Anti-HA antibodies.
• Western blot detection using anti-HA monoclonal antibodies.
• Immunofluorescence staining for subcellular localization studies.
• Facilitating protein-protein interaction mapping in complex biological samples.

This article extends the detailed mechanistic and troubleshooting perspectives found in the LabPE article by providing new quantitative benchmarks and updated best practices for optimizing HA peptide-mediated elution.

Common Pitfalls or Misconceptions

• The HA peptide does not universally elute all HA-tagged proteins; elution efficiency depends on fusion protein conformation and antibody accessibility.
• Excessive peptide concentration can cause antibody denaturation or non-specific elution.
• Long-term storage of HA peptide solutions is discouraged due to potential hydrolysis and activity loss.
• The HA tag is not suitable for in vivo tracking in organisms expressing endogenous influenza hemagglutinin.
• Cross-reactivity may occur if anti-HA antibodies are not properly characterized.

Workflow Integration & Parameters

For optimal use, dissolve the HA peptide (A6004) in water, DMSO, or ethanol to the desired concentration, considering solubility limits. Add the peptide to the immunoprecipitation elution buffer at 0.1–1 mg/mL, incubating at 4°C for 30–60 minutes with gentle agitation. Collect the eluted HA-tagged proteins by centrifugation or magnetic separation. For Western blot or immunofluorescence, use validated monoclonal Anti-HA antibodies at 1:1000–1:5000 dilution. Always store dry peptide at -20°C, desiccated, and prepare fresh solutions to maximize activity. For troubleshooting and comparative workflow analysis, readers may refer to this internal article, which this review updates with expanded quantitative parameters and evidence-based recommendations.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide from APExBIO (A6004) is a rigorously benchmarked, high-purity reagent enabling sensitive protein detection and purification in modern molecular biology. Its robust solubility, specificity, and compatibility with immunoprecipitation and protein-protein interaction assays position it as a standard tool in research. As methodologies evolve, continued optimization and adoption of standardized peptide tags will drive reproducibility and innovation in protein analysis. For further product-specific data and ordering information, visit the APExBIO Influenza Hemagglutinin (HA) Peptide page.